enkel voor onderzoeksdoeleinden

Avexitide

Cat.Nr.P1203

Avexitide (Exendin (9-39)amide) is een specifieke en competitieve antagonist van de glucagon-like peptide-1 (GLP-1) receptor.

Amino-zuursequentie

CAS-nr. 133514-43-9

Sellecks Avexitide Is geciteerd door 1 Publicatie

Kwaliteitscontrole

Batch: Zuiverheid: 99.81%

99.81

Opslag (vanaf de datum van ontvangst)	3 years-20°C powder	Opslag van stamoplossingen Verdeel de stamoplossingen om herhaalde vries-dooi cycli te voorkomen	1 year-80°Cin solvent
			1 month-20°Cin solvent

In vitro
Batch:

DMSO : 100 mg/mL (29.67 mM)；
(Met vocht verontreinigde DMSO kan de oplosbaarheid verminderen. Gebruik verse, watervrije DMSO.)

Water : 100 mg/mL

Ethanol : 100 mg/mL

In Vivo Batch: Voeg oplosmiddelen afzonderlijk en in volgorde toe aan het product.					In vivo Formulecalculator
	Homogeneous suspension	CMC-NA	≥5mg/ml	Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.	In vivo Formulecalculator
Clear solution	5%DMSO 1 40%PEG300 2 5%Tween80 3 50%ddH2O	5.000mg/ml (1.48mM)	Taking the 1 mL working solution as an example, add 50 μL of 100 mg/ml clarified DMSO stock solution to 400 μL of PEG300, mix evenly to clarify it; add 50 μL of Tween80 to the above system, mix evenly to clarify; then continue to add 500 μL of ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results.
Clear solution	5% DMSO 1 95% Corn oil	0.830mg/ml (0.25mM)	Taking the 1 mL working solution as an example, add 50 μL of 16.6 mg/ml clear DMSO stock solution to 950 μL of corn oil and mix evenly. The mixed solution should be used immediately for optimal results.
Homogeneous suspension	CMC-NA	≥5mg/ml	Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.

Beschrijving	Avexitide (Exendin (9-39)amide) is een specifieke en competitieve antagonist van de glucagon-like peptide-1 (GLP-1) receptor.
Targets/IC₅₀/Ki	GLP-1 receptor

Referenties
https://pubmed.ncbi.nlm.nih.gov/18635551/

Molecuulformule	C₁₄₉H₂₃₄N₄₀O₄₇S
Molecuulgewicht	3369.76
CAS-nr.	133514-43-9
Uiterlijk	White Powder
Peptidegehalte (per %N)	≥80%
Enkele onzuiverheid (per HPLC)	≤1.0%
Analyse (door watervrij, azijnzuurvrij)	95.0~105.0%
MS	Consistent
Verpakking	plastic vial(dedicated for peptide packing) or glass vial, quantity according to customer's detail requirement.
Opslag (Vanaf de datum van ontvangst)	3 years-20°C powder
Verzending	Verzending bij kamertemperatuur (Stabiliteitstests tonen aan dat dit product zonder koelmaatregelen kan worden verzonden.)